Drug
SK3530
SK3530 is a pharmaceutical drug with 6 clinical trials. Historical success rate of 83.3%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
83.3%
Based on 5 completed trials
Completion Rate
83%(5/6)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(17%)
Phase Distribution
Ph phase_2
1
17%
Ph phase_1
3
50%
Ph phase_3
2
33%
Phase Distribution
3
Early Stage
1
Mid Stage
2
Late Stage
Phase Distribution6 total trials
Phase 1Safety & dosage
3(50.0%)
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
2(33.3%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
83.3%
5 of 6 finished
Non-Completion Rate
16.7%
1 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(5)
Terminated(1)
Detailed Status
Completed5
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
83.3%
Most Advanced
Phase 3
Trials by Phase
Phase 13 (50.0%)
Phase 21 (16.7%)
Phase 32 (33.3%)
Trials by Status
terminated117%
completed583%
Recent Activity
0 active trials
Showing 5 of 6
completedphase_3
Study to Assess the Efficacy and Safety of SK3530 on Erectile Dysfunction in Patients With Diabetes Mellitus
NCT00705861
completedphase_1
Phase 1 Study of SK3530 to Investigate of the Effect of Food
NCT00443625
completedphase_3
Phase III Study to Assess the Efficacy and Safety of SK3530 in Patients With Erectile Dysfunction and Hypertension
NCT00644007
completedphase_1
Phase I Study to Investigate the Drug Interaction After Oral Administration of Tamsulosin and SK3530
NCT00489606
completedphase_1
Phase I Study to Investigate the Alcohol Interaction of SK3530
NCT00489450
Clinical Trials (6)
Showing 6 of 6 trials
NCT00705861Phase 3
Study to Assess the Efficacy and Safety of SK3530 on Erectile Dysfunction in Patients With Diabetes Mellitus
NCT00443625Phase 1
Phase 1 Study of SK3530 to Investigate of the Effect of Food
NCT00644007Phase 3
Phase III Study to Assess the Efficacy and Safety of SK3530 in Patients With Erectile Dysfunction and Hypertension
NCT00489606Phase 1
Phase I Study to Investigate the Drug Interaction After Oral Administration of Tamsulosin and SK3530
NCT00489450Phase 1
Phase I Study to Investigate the Alcohol Interaction of SK3530
NCT00351065Phase 2
Phase II Trial of SK3530 in Erectile Dysfunction
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6